This challenge appears across care settings: stigma around injectables and concerns about legitimacy lead some patients to hide use or chase unverified sources, which raises safety issues
JAMA 312:26682675 UK Prospective Diabetes Study (UKPDS) Group (1998) Effect of intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
The most common side effects include nausea, diarrhea, constipation, headache, vomiting, and low blood sugar
It is quite possible that a state of on-going chronic inflammation with reduced anti-oxidant mechanisms may underlie the not infrequent association between CSU and metabolic syndrome
Primary Research Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling